Another study identified similarly increased activity of the endocytic pathway in neurons and endothelia in brains of persons with certain APP mutations and sporadic AD that was not present in persons with PSEN1 mutations [32], also suggesting divergent disease mechanisms. This evidence concerns the gene PSEN1 and Alzheimer disease.